Immune Modulator Drugs Improved Survival for People Hospitalized with COVID-19
SC CTSI collaborated with the National Center for Advancing Translational Sciences and other CTSAProgram hubs to implement The National Institutes of Health’s ACTIV-1 Immune Modulators Clinical Trial.